| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advanced Heart Failure in the Cardiac Intensive Care Unit
|
Jentzer, Jacob C.
|
|
|
11 |
2 |
p. 252-254
|
artikel
|
| 2 |
Applicability of Vericiguat to Patients Hospitalized for Heart Failure in the United States
|
Khan, Muhammad Shahzeb
|
|
|
11 |
2 |
p. 211-223
|
artikel
|
| 3 |
Approaches to Genetic Screening in Cardiomyopathies
|
Kontorovich, Amy R.
|
|
|
11 |
2 |
p. 133-142
|
artikel
|
| 4 |
Augmentation of Natriuretic Peptide Bioactivity via Combined Inhibition of Neprilysin and Phosphodiesterase-9 in Heart Failure
|
Scott, Nicola J.A.
|
|
|
11 |
2 |
p. 227-239
|
artikel
|
| 5 |
Cardiopulmonary Exercise Testing With Simultaneous Echocardiography
|
Verwerft, Jan
|
|
|
11 |
2 |
p. 243-249
|
artikel
|
| 6 |
Clinical Presentation and In-Hospital Trajectory of Heart Failure and Cardiogenic Shock
|
Hernandez-Montfort, Jaime
|
|
|
11 |
2 |
p. 176-187
|
artikel
|
| 7 |
Editorial Board
|
|
|
|
11 |
2 |
p. i-v
|
artikel
|
| 8 |
Effectiveness of Telemedicine Services After Hospitalization for Heart Failure
|
Khan, Muhammad Shahzeb
|
|
|
11 |
2 |
p. 207-210
|
artikel
|
| 9 |
Full issue PDF
|
|
|
|
11 |
2 |
p. I-CXLIV
|
artikel
|
| 10 |
Heart Failure With Preserved Ejection Fraction
|
Ryan, John J.
|
|
|
11 |
2 |
p. 250-251
|
artikel
|
| 11 |
How to Measure DELIVERed Benefits of Dapagliflozin in the Management of HFmrEF/HFpEF?
|
Tanaka, Atsushi
|
|
|
11 |
2 |
p. 261
|
artikel
|
| 12 |
Impact of COVID-19 on Heart Failure Clinical Trials
|
Bhatt, Ankeet S.
|
|
|
11 |
2 |
p. 254-257
|
artikel
|
| 13 |
Information for Authors
|
|
|
|
11 |
2 |
p. vi-xiv
|
artikel
|
| 14 |
Inhibiting Both Neprilysin and Phosphodiesterase Type 9
|
Kass, David A.
|
|
|
11 |
2 |
p. 240-242
|
artikel
|
| 15 |
Longer-Term Effects of Remote Patient Management Following Hospital Discharge After Acute Systolic Heart Failure
|
Angermann, Christiane E.
|
|
|
11 |
2 |
p. 191-206
|
artikel
|
| 16 |
Prevention Supersedes Prediction of Worsening Heart Failure ∗
|
Costanzo, Maria Rosa
|
|
|
11 |
2 |
p. 157-160
|
artikel
|
| 17 |
Reply
|
Selvaraj, Senthil
|
|
|
11 |
2 |
p. 261-262
|
artikel
|
| 18 |
Sociodemographic Disparities in the GDMT Usage ∗
|
Parwani, Purvi
|
|
|
11 |
2 |
p. 173-175
|
artikel
|
| 19 |
Temporal Characteristics of Device-Based Individual and Integrated Risk Metrics in Patients With Chronic Heart Failure
|
Zile, Michael R.
|
|
|
11 |
2 |
p. 143-156
|
artikel
|
| 20 |
Treatment Differences in Medical Therapy for Heart Failure With Reduced Ejection Fraction Between Sociodemographic Groups
|
Witting, Celeste
|
|
|
11 |
2 |
p. 161-172
|
artikel
|
| 21 |
Treatment of Advanced (Stage D) Heart Failure in the New Era
|
Bozkurt, Biykem
|
|
|
11 |
2 |
p. 258-260
|
artikel
|
| 22 |
Treatment of Heart Failure Related Cardiogenic Shock
|
Thiele, Holger
|
|
|
11 |
2 |
p. 188-190
|
artikel
|
| 23 |
Vericiguat in HFrEF
|
Kittleson, Michelle M.
|
|
|
11 |
2 |
p. 224-226
|
artikel
|
Tijdschrift beschrijving